FDA Investigator Joseph A Piechocki

Joseph A Piechocki has inspections in 3 countries as of 13 Nov 2023. Joseph A Piechocki has collaborated with a combinined 4262 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, China, Jordan
Co-Investigator(s):
Adam J Wilson, Adree N Anderson, Alan M Barker, Alanna Lmussawwir Bias, Alexandra A Carrico, Alicia M Mozzachio, Amanda M Dunneback, Amy S Graf, Ana Paulap Sandee, Anders W Evenson, Andrace Lde Yampert, Andrea D Swingle, Andrew J Barrowcliff, Anna M Brannen, Anthony F Lorenzo, Anthony J Ladner, Anthony R Bucks, April L Brown, April L Young, Arsen Karapetyan, Art O Czabaniuk, Aurora Miha Trifanov, Aurora Mihaela Trifanov, Azza Talaat, Bei Y He, Benjamin J Smith, Benjamin W Anderson, Bo Chi, PhD, Brent M Dehaan, Brian A Roelofs, Brian D Nicholson, Bruce H Mccullough, Byungja E Marciante, Caroline Strasinger, Carolyn A Warren, Carrie Ann Plucinski, Chad E Schmear, Chad W Rice, Charles I Ann, Charles L Zhou, Chery Grandinetti, Christian D Lynch (CDL), Christopher D Leach, Christopher T Middendorf, Constantin Y Philopoulos, Corrine M Carter, Courtney R Tiegs, Daniel J Brown, David A Paterson, David L Miser, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Deborah M Trout, Debra I Love, Debra L Boyd Seale, Denise L Burosh, Dennis E Guilfoyle, PhD, Dilip Devineni, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward E Lockwood (EEL), Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric M Mueller, PharmD, Erika V Butler, Gregory A Berg, Gretchen Lf Trendel, Hector A Carrero, Howard Sklamberg, Ian L Mcwilliams, Ifueko Osemwota, Ivan E Reyes, Jacob G Lutz, Jacqueline Mdiaz Albertini, James R Evans, James W Plucinski, Janae D Price, Janis R Armedoriz, Jason F Chancey, Jazmine N Brown, Jazmine N Still, Jean Blackston Hill, Jean Blackstone Hill, Jeanne J Thai, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer C Johnson, Jennifer S Ness, Jesse A Vazquez, John M Seale, John N Woodall, Joohi Castelvetere, Joseph A Morkunas, Joseph R Strelnik, Joseph T Madak, Joslyn K Brunelle, PhD, Justin A Boyd, Kalavati Suvarna, PhD, Karen M Montgomery (KMM), Kelley L Clark, Kham Phommachanh, Kristina Fillmore, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Sanger, Lauren E Sexton, Lauren Iacono Connors, PhD, Lauren M Lilly, PhD, Lauren N Howard, Laurie Graham, Leigh Anne Myers, Lequita M Mayhew, Lindsey Brown, PhD, Lisa Hornback, Lisa M Bellows, Lisa R Hilliar, Luella J Rossi, Maf Maf, Maria C Iuga, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Martha Sullivan Myrick, Mary L Schuckmann, Massod Rahimi, PhD, Matthew B Casale, Matthew M Schuckmann, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Miah I Schneider, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Monica E Murie, Monica Murie, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy L Rolli, Neali H Lucas, Nibin Varghese, MS, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole S Williams, Omotunde O Osunsanmi, Ou Ma, Paola S Barnett, Patricia A Cochran, Patricia A Mcilroy, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Peter E Baker, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Rafael Padilla, Rafeeq A Habeeb, Raquel Gonzalez, Raquel Gonzalez Rivera, Raymond T Oji, Rebecca E Dombrowski, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Rohn R Robertson, Rose M Ashley, Ross J Grigsby, Rumany C Penn, PharmD, Russell K Riley, Salwa K Poole, Sandra A Boyd, Sandra Sejdinovic, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Shafiq S Ahadi, Shalonda C Clifford, Sharon K Thoma, PharmD, Sherry G Bous, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Stephen C Mahoney, Stephen D Eich, Steven D Kehoe, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan Yuscius, Suyang Qin, Tara L Greene, Tara L King, Tenzin Jangchup, That Q Dang, Theodore N Sietsema, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tina M Pawlowski, Tina S Roecklein, Vincent Thomas, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, William D Tingley, Yangmin Ning, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yumi J Hiramine, Yvonne E Lozano, Yvonne Lozano, Zhang Zhao, PhD

Joseph A Piechocki's Documents

Publish Date Document Type Title
December, 2022 FDA 483 Amsino Healthcare (USA) Inc. - Form 483, 2022-12-19
October, 2022 EIR Eli Lilly and Company - EIR, 2022-10-21
January, 2023 FDA 483 CofixRX, LLC - Form 483, 2023-01-20
March, 2023 EIR Patheon Biologics LLC - EIR, 2023-03-02
September, 2021 FDA 483 SpecGx LLC - Form 483, 2021-09-17
March, 2023 FDA 483 Patheon Biologics LLC - Form 483, 2023-03-02
September, 2022 FDA 483 Element Materials Technology Ann Arbor LLC - Form 483, 2022-09-09
October, 2022 FDA 483 Eli Lilly and Company - Form 483, 2022-10-21
July, 2021 FDA 483 Grand River Aseptic Manufacturing Inc - Form 483, 2021-07-02
August, 2022 FDA 483 Birchwood Laboratories LLC - Form 483, 2022-08-19
January, 2023 FDA 483 LXR Biotech - Form 483, 2023-01-20
July, 2021 EIR Grand River Aseptic Manufacturing Inc - EIR, 2021-07-02
July, 2021 FDA 483 Par Sterile Products LLC - Form 483, 2021-07-20
November, 2021 FDA 483 Fagron Inc - Form 483, 2021-11-18
June, 2022 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2022-06-30
April, 2022 FDA 483 LGM PHARMA, LLC - Form 483, 2022-04-08
April, 2023 FDA 483 Par Sterile Products LLC - Form 483, 2023-04-14
March, 2023 FDA 483 Response Patheon Biologics LLC - Form 483R, 2023-03-02
July, 2021 FDA 483 Response Grand River Aseptic Manufacturing Inc - Form 483R, 2021-07-26
November, 2022 FDA 483 Corium Innovations, Inc. - Form 483, 2022-11-18
September, 2023 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2023-09-19
September, 2023 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2023-10-09
December, 2023 FDA 483 LAURUS SYNTHESIS PRIVATE LIMITED - Form 483, 2023-12-12
December, 2023 FDA 483 LAURUS SYNTHESIS PRIVATE LIMITED - Form 483, 2023-12-12
August, 2023 FDA 483 Zhuhai United Laboratories Co., Ltd - Form 483, 2023-08-03
December, 2023 FDA 483 LAURUS SYNTHESIS PRIVATE LIMITED - Form 483, 2023-12-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more